The first year of the Trump administration in 2025 shook up the health care industry. Administrative efforts concentrated on significant restructuring and policy changes at the Food and Drug Administration (FDA), focusing on clinical trials, drug approvals, vaccine policy, and more.
Join an expert panel to learn about the recent changes at the FDA and how it impacts health care businesses, the drug approval process, and staffing at the agency.
Moderated by Rachel Sachs from Washington University in St Louis, speakers include:
- Genevieve Kanter, USC Sol Price School of Public Policy
- Holly Fernandez Lynch, Perelman School of Medicine at the University of Pennsylvania
- Chris Meekins, Raymond James
Date: February 17, 2026
Time: 11am – 12 pm ET
